| Date | Title | Description | Source |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадил... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной сви... | incrussia.... |
| 11.03.2024 | Caribou Biosciences Reports Fourth Quarter and Full Year 202... | - | globenewsw... |
| 11.03.2024 | Caribou Biosciences Reports Fourth Quarter and Full Year 202... | -- 30th patient dosed in CB-010 ANTLER Phase 1 trial dose expansion; initial dose expansion data and... | einpresswi... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 05.03.2024 | Caribou Biosciences to Present Preclinical Data on CB-012, a... | - | globenewsw... |
| 10.01.2024 | Caribou Biosciences Secures $155M to Push Company's Pipeline | - | alimentcap... |
| 14.07.2023 | Caribou Biosciences Announces Pricing of Upsized $125 Millio... | /EIN News/ -- BERKELEY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:... | einpresswi... |
| 13.07.2023 | Caribou Biosciences Announces Pricing of Upsized $125 Millio... | - | globenewsw... |
| 06.07.2023 | Caribou Biosciences Announces $25 Million Equity Investment ... | - | globenewsw... |
| 09.05.2023 | Caribou Biosciences Reports First Quarter 2023 Financial Res... | /EIN News/ -- -- CB-010 ANTLER Phase 1 trial enrolling second-line LBCL patients in dose expansion;
... | einpresswi... |
| 09.03.2023 | Caribou Biosciences Reports Fourth Quarter and Full Year 202... | /EIN News/ -- -- CB-010 ANTLER Phase 1 trial in r/r B-NHL ongoing with update planned for H2 2023 --... | einpresswi... |
| 17.11.2022 | Startup Cradle Lets You Design Custom Proteins By Just Typin... | Cradle Team at their site in the Netherlands.Cradle | forbes.com... |
| 18.10.2022 | Caribou Biosciences Presents Case Report on Long-term Follow... | BERKELEY, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a lead... | globenewsw... |
| 01.06.2022 | Caribou Biosciences Announces Webcast Conference Call to Hig... | BERKELEY, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a lead... | globenewsw... |
| 17.05.2022 | EXCLUSIVE: Anterra closes $260m Fund II, says quality of agr... | Agtech investment firm Anterra Capital has closed its second Global Food and Agriculture Technology ... | agfunderne... |
| 12.05.2022 | Caribou Biosciences Announces Positive Initial Data for CB-0... | -- 100% ORR (5 of 5 patients) and 80% CR (4 of 5 patients) achieved following 1 dose at the
initial ... | globenewsw... |
| 10.05.2022 | Pow.bio’s continuous fermentation technology might be the ke... | Fermentation, the process of breaking down sugars using the enzymes of microorganisms, is almost as ... | beepartner... |
| 03.05.2022 | Caribou Biosciences to Present at Upcoming Investor Conferen... | BERKELEY, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leadi... | globenewsw... |
| 08.04.2022 | Caribou Biosciences Presents Positive Preclinical Data for A... | -- CB-011 is an allogeneic anti-BCMA CAR-T cell therapy immune cloaked to blunt both T- and NK-media... | globenewsw... |
| 21.03.2022 | Caribou Biosciences Reports Fourth Quarter and Full Year 202... | -- Company plans to present initial ANTLER Phase 1 clinical data at a medical meeting in 2022 for CB... | globenewsw... |
| 07.02.2022 | Caribou Biosciences to Present at the SVB Leerink 11th Annua... | BERKELEY, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leadi... | globenewsw... |
| 08.11.2021 | Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to... | BERKELEY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a lead... | globenewsw... |
| 20.10.2021 | Caribou Biosciences to Present at Upcoming Investor Conferen... | BERKELEY, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leadi... | globenewsw... |
| 02.09.2021 | Caribou Biosciences : Completed upsized initial public offer... | Completed upsized initial public offering of common stock, raising$349.6 million in gross proceeds i... | marketscre... |
| 26.07.2021 | Caribou raises $304M in one of gene editing’s most lucrative... | From Biopharma Dive | anterracap... |
| 23.07.2021 | Caribou raises $304M in one of gene editing’s most lucrative... | - | fprimecapi... |
| 04.03.2021 | Caribou Biosciences Raises $115M in Series C Funding | Caribou Biosciences, Inc., a Berkeley, Calif.-based clinical-stage CRISPR genome editing biotechnolo... | finsmes.co... |
| 03.03.2021 | Caribou Biosciences Raises $115M Series C Financing to Advan... | BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome e... | avego.com/... |
| 03.03.2021 | Caribou nets $115M to boost CRISPR tech, advance off-the-she... | Original from: Fierce Biotech | anterracap... |
| 03.03.2021 | Caribou Biosciences Raises $115M Series C |
BERKELEY, CA, Caribou Biosciences, a genome editing biotechnology company, has completed an oversu... | vcnewsdail... |
| 09.10.2020 | Pontifax AgTech closes latest fund at $302m | Pontifax AgTech has closed its newest fund with $302 million raised, making it one of the world’s la... | agfunderne... |
| 12.08.2019 | Announcing the Disrupt SF 2019 agenda | Disrupt SF 2019 is set to be the biggest and best Disrupt yet. We’ve got a little something for ever... | techcrunch... |
| 13.06.2018 | Tropic Biosciences Raises $10m Series A for Tropical CRISPR ... | Tropic Biosciences, the UK-based startup using gene-editing technology including CRISPR to optimize ... | agfunderne... |
| 15.01.2018 | EXCLUSIVE: Biotech Dominates THRIVE Top 50 in AgTech List | Biotech and predictive analytics startups dominate the Salinas, CA-based THRIVE AgTech’s Top 50 list... | agfunderne... |
| 28.07.2017 | Gene Editing Gets Public Market Approval as Calyxt Raises $6... | Gene editing has caused a lot of excitement in agriculture technology circles for its potential to p... | agfunderne... |
| 16.05.2017 | Caribou Bioscience’s CEO on CRISPR’s legal and ethical chall... | Caribou Bioscience co-founder and CEO Rachel Haurwitz joined us onstage at Disrupt this morning to h... | techcrunch... |
| 30.03.2017 | Will Consumer Acceptance Be The Challenge for CRISPR Technol... | Gene editing was a key topic discussed at this week’s World Agri-Tech Innovation Summit in San Franc... | agfunderne... |
| 28.12.2016 | Best of 2016: AgFunder’s 10 Most Read Stories | It’s been a busy year for AgFunder as our member and subscriber base grew to over 25,000 and we post... | agfunderne... |
| 05.10.2016 | How Does Agtech Fit an Impact Investing Thesis? | Editor’s Note: I recently attended SOCAP, the largest conference for the impact investing community,... | agfunderne... |
| 05.10.2016 | Connecting the Dots: Trends in Crop Protection and Animal He... | Editor’s Note: Kevin Zussman is an agtech investor with Cultivian Sandbox, a venture capital firm th... | agfunderne... |
| 09.06.2016 | How Big Data is Disrupting Agriculture from Biological Disco... | Editor’s Note: Vonnie Estes is an agtech consultant with a particular focus on building biotech-focu... | agfunderne... |
| 19.05.2016 | Fundings-in-Brief: Precision Ag Startups from Outside the US... | Avrio Capital Completes Three Investments
Avrio Capital has now deployed C$15 million of capital fro... | agfunderne... |
| 16.05.2016 | Caribou Biosciences Completes $30M Series B Funding | Caribou Biosciences, Inc., a Berkeley, California-based developer of CRISPR-Cas technologies for gen... | finsmes.co... |
| 16.05.2016 | CRISPR Startup Caribou Biosciences Raises $30m Series B as G... | Caribou Biosciences, a startup founded by Jennifer Doudna, the scientist largely attributed with the... | agfunderne... |
| 17.03.2016 | Monsanto’s Fraley on Staying Ahead in Agtech Innovation | Representatives from four of the world’s biggest agribusinesses gathered yesterday at the World Agri... | agfunderne... |
| 11.08.2015 | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here ... | But that’s already turned quickly on its head.
Confidence is growing in the technology, as evidenced... | medcitynew... |
| 23.06.2015 | Five conspicuous omissions from MIT Tech Review’s 50 smartes... | …we did not have trouble finding big ideas. To make the list, a company must have truly innovative t... | medcitynew... |
| 13.05.2015 | The Genome Engineering Revolution | Ryan Clarke Contributor
More posts by this contributor
A Third Act For Biofuels
James Hyun Contribut... | techcrunch... |
| 02.04.2015 | Caribou Biosciences Closes $11M Series A Financing Round | Caribou Biosciences, a Berkeley, Calif.-based developer of technology-based solutions for cellular e... | finsmes.co... |
| - | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here ... | CRISPR/Cas9 gene editing has zoomed to the forefront of the biotech investment scape in the past yea... | medcitynew... |
| - | Caribou Biosciences Secures $155M to Push Company's Pipeline | "CRISPR pioneer Caribou Biosciences secured $115 million in an oversubscribed Series C financin... | pontifaxag... |
| - | Five conspicuous omissions from MIT Tech Review’s 50 smartes... | We know who made the cut in the latest MIT Technology Review list of the 50 Smartest Companies of 20... | medcitynew... |
| - | Caribou Biosciences Raises $115M Series C Financing to Advan... | BERKELEY, Calif.--(BUSINESS WIRE)--Mar 3, 2021--
Caribou Biosciences, Inc., a leading clinical-stage... | oaoa.com/n... |
